| Elkayam, Ori |
| Recruiting | 1/2 | 160 | Europe, RoW | Allocetra, Placebo | Enlivex Therapeutics Ltd., Nordic Bioscience Clinical Development (NBCD) | Osteoarthritis, Knee | 06/25 | 02/26 | | |
| Not yet recruiting | 1 | 6 | RoW | Allocetra | Enlivex Therapeutics Ltd. | Arthritis, Psoriatic | 01/26 | 01/26 | | |
NCT06271746: Treatment of Fibromyalgia With the FibroNova Neuromodulation Device |
|
|
| Recruiting | N/A | 170 | US, RoW | FibroNova (Active mode), FibroNova (Sham mode) | Theranica | Fibromyalgia | 03/25 | 06/25 | | |
| Giladi, Nir |
NCT05693207: EMG to Detect and Monitor Freezing of Gait Among People With Parkinson's Disease |
|
|
| Recruiting | N/A | 30 | RoW | EMG, Accelerometers and gyroscopes | Tel-Aviv Sourasky Medical Center | Evaluation of Muscle Contraction in People With PD | 05/23 | 12/23 | | |
NCT04324333: Modelling Missteps to Improve Fall Risk Assessment. |
|
|
| Recruiting | N/A | 200 | RoW | Digital wearable system, Digital wearable system (Owlytics Healthcare's app) | Tel-Aviv Sourasky Medical Center, Owlytics Healthcare | Fall Patients | 12/24 | 12/24 | | |
| Recruiting | N/A | 4500 | Europe, Canada, US, RoW | | Michael J. Fox Foundation for Parkinson's Research, Institute for Neurodegenerative Disorders | Parkinson Disease | 12/33 | 12/33 | | |
| Viskin, Sami |
| Recruiting | N/A | 100 | Canada, US, RoW | Invasive Electrophysiology Study | Western University, Canada, Canadian Institutes of Health Research (CIHR) | Sudden Cardiac Death | 01/25 | 01/25 | | |
| Brill, Silviu |
NCT04047927: A Single Arm, Open-label First In Human Study for Assessing the Safety and Performance of the EpiFinder in Subjects With Clinical Indication for Lumbar Epidural Steroids Injection (ESI) |
|
|
| Recruiting | N/A | 15 | RoW | EpiFinder | Omeq Medical | Chronic Pain | 11/21 | 11/21 | | |
| Banai, Shmuel |
NCT01566175: Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization |
|
|
| Recruiting | N/A | 100 | RoW | Neovac coronary sinus reducer, Reducer | Tel-Aviv Sourasky Medical Center, Neovasc Inc. | Refractory Angina | 12/30 | 12/31 | | |
| Arbel, Yaron |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) |
|
|
| Recruiting | 3 | 10000 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | 02/29 | 02/29 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
| Active, not recruiting | 2 | 109 | Europe, Canada, US, RoW | CardiolRx, Cannabidiol | Cardiol Therapeutics Inc., Cardiol Therapeutics Inc. | Acute Myocarditis | 01/25 | 02/25 | | |
| Ablin, Jacob N |
NCT05644054: The Impact of THC on Pain Modulation in Fibromyalgia |
|
|
| Recruiting | N/A | 40 | RoW | THC, Placebo | Tel Aviv Medical Center | Fibromyalgia, Primary | 04/24 | 12/24 | | |
| Freifeld, Yuval |
| Recruiting | N/A | 264 | RoW | Mitomycin/Gemcitabine, Saline | Carmel Medical Center | UTUC | 01/28 | 01/28 | | |
NCT04543903: Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer |
|
|
| Recruiting | N/A | 10 | RoW | Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT) | Alpha Tau Medical LTD. | Prostate Adenocarcinoma | 12/24 | 05/25 | | |
| Havakuk, Ofer |
NCT05271214: Conservative Management of Left Ventricular Assist Device Candidates |
|
|
| Recruiting | N/A | 100 | RoW | | Tel-Aviv Sourasky Medical Center | Advanced Heart Failure | 01/28 | 01/28 | | |
| Karni, Arnon |
NCT03362294: Safety and Efficacy of Monthly Long-acting IM Injection of 25mg or 40 mg GA Depot in Subjects With PPMS |
|
|
| Active, not recruiting | 2 | 30 | RoW | GA Depot 40mg once monthly, GA Depot 25mg once monthly | Mapi Pharma Ltd. | Primary Progressive Multiple Sclerosis | 08/26 | 09/26 | | |
NCT03696485: Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS |
|
|
| Withdrawn | 1/2 | 12 | RoW | SCM-010 | Stem Cell Medicine Ltd. | Secondary Progressive Multiple Sclerosis (SPMS) | 02/25 | 02/25 | | |
| Chorin, Ehud |
NCT04600245: Evaluation of CARTOSOUND FAM Software for Accurate Reconstruction of the Left Atrium |
|
|
| Recruiting | N/A | 60 | RoW | Evaluation of CARTOSOUND-FAM software for accurate three-dimensional reconstruction of the left atrium in patients referred for atrial fibrillation ablation. | Tel-Aviv Sourasky Medical Center | Atrial Fibrillation | 10/21 | 10/23 | | |
NCT04592497: Evaluation of the Safety and Performance of the Very High Power-Short Duration QDOT |
|
|
| Not yet recruiting | N/A | 60 | RoW | AF ablation | Tel-Aviv Sourasky Medical Center | Atrial Fibrillation | 10/21 | 10/22 | | |
NCT05872776: BEAT AF - Braking Ectopic Atrial Trends In Atrial Fibrillation |
|
|
| Recruiting | N/A | 50 | RoW | Neuromodulation with RR2 device, Mock sham neuromodulation with sham RR2 device | Ziv HealthCare Ltd. | Paroxysmal Atrial Fibrillation | 12/24 | 03/25 | | |
| Recruiting | N/A | 500 | RoW | Sport SICD | Eli Sprecher, MD | Patients With an Implanted S-ICD Who Continue to Exercise Regularly | 01/26 | 01/29 | | |
| Arber, Nadir |
| Not yet recruiting | 3 | 1800 | RoW | Aspirin, acetylsalicylic acid | Tel-Aviv Sourasky Medical Center, Rambam Health Care Campus, Rabin Medical Center, Soroka University Medical Center, Sheba Academic Medical Center Hospital | Lynch Syndrome I (Site-specific Colonic Cancer) | 09/27 | 09/27 | | |
NCT05947747: Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS |
|
|
| Recruiting | 2b | 90 | RoW | EXO-CD24, Exosomes Overexpressing CD24, Placebo | Nano24med | ARDS | 12/25 | 12/25 | | |
NCT04747574: Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection |
|
|
| Recruiting | 1 | 35 | RoW | EXO-CD24 | Tel-Aviv Sourasky Medical Center | SARS-CoV-2 | 02/21 | 03/21 | | |
NCT06255041: Detection of Cancer in Breath Samples by Trained Detection Dogs |
|
|
| Recruiting | N/A | 1250 | RoW | | SpotitEarly | Breast Cancer, Colorectal Cancer, PROSTATE CANCER, Lung Cancer | 01/24 | 03/24 | | |
NCT05268406: Evaluation of C-Scan in Identifying Subjects With Elevated Risk of Polyps in the Colon |
|
|
| Recruiting | N/A | 800 | RoW | C-Scan System | Check-Cap Ltd. | Healthy Subjects | 05/23 | 08/23 | | |
| Recruiting | N/A | 2000 | RoW | Blood-based liquid biopsy | Tel-Aviv Sourasky Medical Center, Tel Aviv Medical Center | Cancer, Early Detection of Cancer | 09/24 | 09/27 | | |
909REM, NCT04847622: Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir. |
|
|
| Completed | N/A | 451 | Europe, RoW | Remdesivir | NEAT ID Foundation, Gilead Sciences | Covid19 | 04/21 | 04/21 | | |
| Maslovitz, Sharon |
NCT04653506: Paracetamol / Ibuprofen for Postpartum Pain in the Early Postpartum Period |
|
|
| Completed | N/A | 107 | RoW | Paracetamol 1000 mg, Ibuprofen 400 mg | Tel-Aviv Sourasky Medical Center | Pain | 07/22 | 07/23 | | |
| Chorin, Udi |
NCT02818517: Evaluation and Management of Cardio Toxicity in Oncologic Patients |
|
|
| Recruiting | N/A | 1000 | RoW | ACE inhibitors, beta blockers | Tel-Aviv Sourasky Medical Center | Heart Failure | 11/30 | 12/31 | | |
| Perl, Michal Laufer |
DETECT-HF, NCT06378632: AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM |
|
|
| Recruiting | N/A | 500 | Europe, US, RoW | Hearo App | Cordio Medical | Heart Failure | 01/25 | 03/25 | | |
NCT03142659: Evaluation and Management of Heart Failure Patients |
|
|
| Recruiting | N/A | 5000 | RoW | registry-no intervention | Tel-Aviv Sourasky Medical Center | Heart Failure | 12/30 | 12/31 | | |
| Topaz, Moris |
NCT01770067: Salvage of Infected Cardiovascular Implantable Electronic Devices (CIED) by Localized High-dose Antibiotics |
|
|
| Recruiting | N/A | 100 | RoW | CITA-RNPT, Extraction of infected CIED | Hillel Yaffe Medical Center | Infection | 02/23 | 02/23 | | |
| Brill, Ayelet |
| Recruiting | N/A | 150 | RoW | | Sheba Medical Center, ElMindA Ltd | Fragile X Associated Tremor-ataxia Syndrome, FXTAS | 12/21 | 12/22 | | |
| Rozenbaum, Zach |
| Not yet recruiting | 3 | 32 | US | Angiography | Tulane University | Acute Kidney Injury | 03/25 | 03/25 | | |
| Platner, Nurit |
| Recruiting | 3 | 852 | Europe, Canada, US, RoW | VE303, Placebo | Vedanta Biosciences, Inc. | Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, CDI, C. Diff Infection, Recurrent Clostridium Difficile Infection, C.Difficile Diarrhea, Diarrhea Infectious | 06/27 | 10/27 | | |
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, ) |
|
|
| Recruiting | 3 | 450 | Europe, US, RoW | Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio | Evopoint Biosciences Inc. | Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia | 04/25 | 12/25 | | |
| Margaria, Megan |
NCT04840784: First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML |
|
|
| Terminated | 1a/1b | 9 | RoW | ETH-155008, study drug | Shengke Pharmaceuticals Pty Ltd | NHL, Leukemia | 05/23 | 05/23 | | |
NCT04402541: Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome |
|
|
| Completed | 1 | 55 | US, RoW | CB-5339, CB-5339 Tosylate | Cleave Therapeutics, Inc. | Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndromes | 07/23 | 07/23 | | |
WUN101-01, NCT05470140: A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML) |
|
|
| Active, not recruiting | 1 | 9 | US, RoW | WU-NK-101 | Wugen, Inc. | Acute Myeloid Leukemia | 10/24 | 01/25 | | |
ANTLER, NCT04637763: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1 | 72 | US, RoW | CB-010, Cyclophosphamide, Fludarabine | Caribou Biosciences, Inc. | Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma, Lymphoma, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma | 08/25 | 09/25 | | |
| Laufer, Michal |
NCT02818517: Evaluation and Management of Cardio Toxicity in Oncologic Patients |
|
|
| Recruiting | N/A | 1000 | RoW | ACE inhibitors, beta blockers | Tel-Aviv Sourasky Medical Center | Heart Failure | 11/30 | 12/31 | | |
NCT03142659: Evaluation and Management of Heart Failure Patients |
|
|
| Recruiting | N/A | 5000 | RoW | registry-no intervention | Tel-Aviv Sourasky Medical Center | Heart Failure | 12/30 | 12/31 | | |
| Piva, Tommaso |
| Recruiting | N/A | 5000 | Europe | Medical history and functional evaluation, Health education | Università degli Studi di Ferrara | Cardiovascular Diseases, Physical Inactivity, Aging, Quality of Life, Physician-Patient Relations | 12/23 | 12/47 | | |
| Recruiting | N/A | 150 | Europe, Canada, RoW | Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure | 09/25 | 12/26 | | |
| Recruiting | N/A | 100 | Europe | Physical activity, Cognitive rehabilitation program | Università degli Studi di Ferrara | Schizophrenia | 12/25 | 12/25 | | |
| Yannakou, Costas |
| Recruiting | 2b | 102 | Europe, Canada, US, RoW | DPX-Survivac, maveropepimut-S, Pembrolizumab, MK-3475, Keytruda, CPA, Intermittent, low-dose cyclophosphamide, Procytox, Cytoxan | ImmunoVaccine Technologies, Inc. (IMV Inc.), Merck Sharp & Dohme LLC | Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma | 10/24 | 04/25 | | |
COALITION, NCT04914741: A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) |
|
|
| Active, not recruiting | 1/2 | 80 | RoW | Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone, Glofitamab, RO7082859, CD20-TCB, Polatuzumab vedotin | Peter MacCallum Cancer Centre, Australia, Hoffmann-La Roche | Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma | 12/23 | 07/25 | | |
NCT04840784: First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML |
|
|
| Terminated | 1a/1b | 9 | RoW | ETH-155008, study drug | Shengke Pharmaceuticals Pty Ltd | NHL, Leukemia | 05/23 | 05/23 | | |
NCT03537482: APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies |
|
|
| Recruiting | 1 | 90 | US, RoW | APG-2575 | Ascentage Pharma Group Inc. | Hematologic Malignancies | 09/24 | 02/25 | | |
NCT04402541: Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome |
|
|
| Completed | 1 | 55 | US, RoW | CB-5339, CB-5339 Tosylate | Cleave Therapeutics, Inc. | Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndromes | 07/23 | 07/23 | | |
ANTLER, NCT04637763: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1 | 72 | US, RoW | CB-010, Cyclophosphamide, Fludarabine | Caribou Biosciences, Inc. | Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma, Lymphoma, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma | 08/25 | 09/25 | | |
| Steinvil, Arik |
NCT02023060: Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation |
|
|
| Recruiting | N/A | 100 | RoW | | Sheba Medical Center | Trans Catheter Aortic Valve, Aortic Stenosis | 11/30 | 11/30 | | |
| Glodstein, Michaela |
| Completed | N/A | 10 | RoW | | Notal Vision Ltd. | A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF Treatment | 07/22 | 03/23 | | |
| Completed | N/A | 58 | RoW | NOTAL-OCT V3.0, OCT scan | Notal Vision Ltd. | AMD, DR | 01/23 | 03/23 | | |
| Ben-Ami, Ronen |
PETERPEN, NCT03671967: PipEracillin Tazobactam Versus MERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae |
|
|
| Recruiting | 4 | 1084 | Canada, RoW | Piperacillin/tazobactam, Meropenem | Rambam Health Care Campus, Rabin Medical Center, University of Modena and Reggio Emilia, Tel Aviv Medical Center, Meir Medical Center, Soroka University Medical Center, The Chaim Sheba Medical Center, McGill University Health Centre/Research Institute of the McGill University Health Centre, Jewish General Hospital, Canadian Institutes of Health Research (CIHR), Hadassah Medical Organization | Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia | 01/26 | 04/26 | | |
| Recruiting | 3 | 225 | Europe, Canada, Japan, US, RoW | Olorofim, Olorofim (F901318), AmBisome®, AmBisome® (liposomal amphotericin B) | F2G Biotech GmbH, Iqvia Pty Ltd, Shionogi | Invasive Aspergillosis | 09/25 | 11/26 | | |
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, ) |
|
|
| Recruiting | 3 | 450 | Europe, US, RoW | Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio | Evopoint Biosciences Inc. | Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia | 04/25 | 12/25 | | |
| Recruiting | 2 | 24 | RoW | Allocetra-OTS | Hadassah Medical Organization, Barzilai Medical Center, Tel-Aviv Sourasky Medical Center | Covid19 | 02/21 | 03/21 | | |
| Completed | 2 | 203 | Europe, US, RoW | Olorofim, F901318 | F2G Biotech GmbH, Iqvia Pty Ltd | Invasive Fungal Infections | 02/23 | 02/23 | | |
| Moshe, Yakir |
NCT04334993: Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Study |
|
|
| Recruiting | 2 | 110 | RoW | Blinatumomab, AIEOP-BFM 2009 protocol - multiagent chemothertapy protocol backbone | Israeli Medical Association | Philadelphia-Negative ALL, High-Risk Cancer | 05/23 | 05/25 | | |
| Recruiting | 2 | 140 | Europe, US, RoW | KER-050 | Keros Therapeutics, Inc., Keros Therapeutics, Inc. | Myelodysplastic Syndromes, Cytopenia | 06/25 | 11/25 | | |
|
|
ITALLI001, NCT05054465: A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALL |
|
|
| Not yet recruiting | 1b | 48 | RoW | Navitoclax, Venetoclax | Israeli Medical Association, Rabin Medical Center, Sheba Medical Center, Rambam Health Care Campus, Tel Aviv Medical Center, Soroka University Medical Center, Shaare Zedek Medical Center, Hadassah Medical Center | Acute Lymphoblastic Leukemia | 08/25 | 08/26 | | |
| Paran, Daphna |
TOPAZ-2, NCT04961567 / 2020-005776-35: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus |
|
|
| Recruiting | 3 | 540 | Europe, Canada, Japan, US, RoW | Litifilimab, BIIB059, Placebo | Biogen | Lupus Erythematosus, Systemic | 09/25 | 03/26 | | |
| shprecher, eli |
NCT04711408: Virtual Reality During Ultrasound Examination of Women With Endometriosis |
|
|
| Recruiting | N/A | 100 | RoW | SootheVR: AppliedVR, Los Angeles, California a head-mounted displa | Tel-Aviv Sourasky Medical Center | Chronic Pain, Pelvic Pain, Endometriosis | 06/23 | 12/23 | | |
NCT04742543: Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia |
|
|
| Recruiting | N/A | 100 | RoW | SootheVR: AppliedVR, Los Angeles, California a head-mounted display | Tel-Aviv Sourasky Medical Center | Dysplasia, Cervix | 03/24 | 03/24 | | |
| ram, shai |
NCT04653506: Paracetamol / Ibuprofen for Postpartum Pain in the Early Postpartum Period |
|
|
| Completed | N/A | 107 | RoW | Paracetamol 1000 mg, Ibuprofen 400 mg | Tel-Aviv Sourasky Medical Center | Pain | 07/22 | 07/23 | | |
| Cohen, Aviad |
NCT04711408: Virtual Reality During Ultrasound Examination of Women With Endometriosis |
|
|
| Recruiting | N/A | 100 | RoW | SootheVR: AppliedVR, Los Angeles, California a head-mounted displa | Tel-Aviv Sourasky Medical Center | Chronic Pain, Pelvic Pain, Endometriosis | 06/23 | 12/23 | | |
| Micklethwaite, Kenneth |
ACTRN12619000079145: Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Chemotherapy |
|
|
| Not yet recruiting | 1 | 20 | | | Western Sydney Local Health District, Westmead Hospital, National Health and Medical Research Council | Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukaemia, Non-Hodgkins Lymphoma | | | | |
ACTRN12617001579381: Safety of Immune Cells for Patients with Relapsed Leukaemia or Lymphoma after Bone Marrow Transplant |
|
|
| Recruiting | 1 | 20 | | | Western Sydney Local Health District, Westmead Hospital, National Health and Medical Research Council | Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukaemia, Non-Hodgkins Lymphoma | | | | |
ANTLER, NCT04637763: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1 | 72 | US, RoW | CB-010, Cyclophosphamide, Fludarabine | Caribou Biosciences, Inc. | Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma, Lymphoma, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma | 08/25 | 09/25 | | |
| Lev, Hadar Moran |
NCT05181176: Effect of Coffee and Tea Consumption on Adolescent Weight Control |
|
|
| Recruiting | N/A | 63 | RoW | Coffee, Green tea, Herbal tea (placebo) | Tel-Aviv Sourasky Medical Center | Body Weight | 12/22 | 01/23 | | |
| Recruiting | N/A | 60 | RoW | description | Tel-Aviv Sourasky Medical Center | Obesity, Metabolic Syndrome | 12/24 | 01/25 | | |
| Barlas, Connie |
| Recruiting | 2b | 102 | Europe, Canada, US, RoW | DPX-Survivac, maveropepimut-S, Pembrolizumab, MK-3475, Keytruda, CPA, Intermittent, low-dose cyclophosphamide, Procytox, Cytoxan | ImmunoVaccine Technologies, Inc. (IMV Inc.), Merck Sharp & Dohme LLC | Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma | 10/24 | 04/25 | | |
ANTLER, NCT04637763: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1 | 72 | US, RoW | CB-010, Cyclophosphamide, Fludarabine | Caribou Biosciences, Inc. | Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma, Lymphoma, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma | 08/25 | 09/25 | | |
| Agbaria, Yara |
NCT05644054: The Impact of THC on Pain Modulation in Fibromyalgia |
|
|
| Recruiting | N/A | 40 | RoW | THC, Placebo | Tel Aviv Medical Center | Fibromyalgia, Primary | 04/24 | 12/24 | | |
| Buzaglo, David |
NCT05693207: EMG to Detect and Monitor Freezing of Gait Among People With Parkinson's Disease |
|
|
| Recruiting | N/A | 30 | RoW | EMG, Accelerometers and gyroscopes | Tel-Aviv Sourasky Medical Center | Evaluation of Muscle Contraction in People With PD | 05/23 | 12/23 | | |
| Ben-Shoshan, Jeremy |
| Recruiting | N/A | 150 | Europe, Canada, RoW | Elective redo transcatheter aortic valve implantation (redo-TAVI), redo-TAVI, redo-TAVR, Valve-in-Valve (ViV), TAV-in-TAV, TAVR-in-TAVR, Revalve | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction, Prosthesis Failure | 09/25 | 12/26 | | |
| Huang, Gillian |
INVISE, NCT06539338: Safety of INT2104 in Participants Aged 18 Years and Older Who Have B-cell Cancer That Came Back After Prior Treatment |
|
|
| Recruiting | 1 | 30 | RoW | INT2104 | Interius BioTherapeutics Inc. | Lymphomas Non-Hodgkin's B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma | 03/28 | 03/31 | | |
ANTLER, NCT04637763: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1 | 72 | US, RoW | CB-010, Cyclophosphamide, Fludarabine | Caribou Biosciences, Inc. | Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma, Lymphoma, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma | 08/25 | 09/25 | | |
| Shmuel, Nurit Ben |
ANTLER, NCT04637763: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1 | 72 | US, RoW | CB-010, Cyclophosphamide, Fludarabine | Caribou Biosciences, Inc. | Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma, Refractory B-Cell Non-Hodgkin Lymphoma, Non Hodgkin Lymphoma, Lymphoma, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma | 08/25 | 09/25 | | |
| Rath, Ehud |
NCT06760559: Does Pre-injection Local Anesthesia Affect Experienced Pain During Intra-articular Hip Injections. |
|
|
| Completed | N/A | 60 | RoW | Intra-articular corticosteroid injection, Local anasthesia | Tel-Aviv Sourasky Medical Center | Pain, Pain Intensity Assessment, Injection, Injection Pain Prevention | 01/22 | 01/22 | | |
